Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 20, 2000

View Archived Issues

Ingenium Raises EUR50M For Work In 'Deductive' Genomics

CAT Signs Development Deals With Oxford Glyco, Wyeth-Ayerst

Mitochondria Studies Raise Hopes For Respiration Disorders Therapy

TMV Aims To Bridge Gap Between Early Financings

Other News To Note

Omrix Has Big Expectations For Biological Glue Product

Gene Therapy For Duchenne's Disease Enters Feasibility Trial

Celltech Profit Represents Milestone For UK Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...